Skip to content

Author

Fatma Elzahraa Ali

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Design, synthesis, and evaluation of novel hydrazide and hydroxamate derivatives as potent antileukemic agents with preferential HDAC-2 inhibitory activity over class I isoform

The development of isoform-selective histone deacetylase (HDAC) inhibitors remains a promising frontier for targeted cancer therapy, offering a strategic opportunity to maximize therapeutic efficacy while minimizing the adverse side effects of pan-HDAC inhibition. In this study, we present a novel series of 4-iodo-3-ni...

Fatma Elzahraa Ali, A. Y. Abdullah Alzahrani, Bandar A. Alyami et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.